Pyrvinium Targets the Unfolded Protein Response to Hypoglycemia and Its Anti-Tumor Activity Is Enhanced by Combination Therapy
Open Access
- 16 December 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (12), e3951
- https://doi.org/10.1371/journal.pone.0003951
Abstract
We identified pyrvinium pamoate, an old anthelminthic medicine, which preferentially inhibits anchorage-independent growth of cancer cells over anchorage-dependent growth (∼10 fold). It was also reported by others to have anti-tumor activity in vivo and selective toxicity against cancer cells under glucose starvation in vitro, but with unknown mechanism. Here, we provide evidence that pyrvinium suppresses the transcriptional activation of GRP78 and GRP94 induced by glucose deprivation or 2-deoxyglucose (2DG, a glycolysis inhibitor), but not by tunicamycin or A23187. Other UPR pathways induced by glucose starvation, e.g. XBP-1, ATF4, were also found suppressed by pyrvinium. Constitutive expression of GRP78 via transgene partially protected cells from pyrvinium induced cell death under glucose starvation, suggesting that suppression of the UPR is involved in pyrvinium mediated cytotoxicity under glucose starvation. Xenograft experiments showed rather marginal overall anti-tumor activity for pyrvinium as a monotherapy. However, the combination of pyrvinium and Doxorubicin demonstrated significantly enhanced efficacy in vivo, supporting a mechanistic treatment concept based on tumor hypoglycemia and UPR.Keywords
This publication has 35 references indexed in Scilit:
- A new inducible RNAi xenograft model for assessing the staged tumor response to mTOR silencingExperimental Cell Research, 2006
- The PERK/eIF2α/ATF4 module of the UPR in hypoxia resistance and tumor growthCancer Biology & Therapy, 2006
- Functional Coupling of p38-Induced Up-regulation of BiP and Activation of RNA-Dependent Protein Kinase–Like Endoplasmic Reticulum Kinase to Drug Resistance of Dormant Carcinoma CellsCancer Research, 2006
- Celecoxib upregulates endoplasmic reticulum chaperones that inhibit celecoxib-induced apoptosis in human gastric cellsOncogene, 2005
- A 96-Well Surrogate Survival Assay Coupled with a Special Short Interfering RNA Vector for Assessing Cancer Gene Targets with Enhanced Signal/Noise Ratio and Its Utility in HTS for Cancer Therapeutic TargetsASSAY and Drug Development Technologies, 2005
- Effect on Tumor Cells of Blocking Survival Response to Glucose DeprivationJNCI Journal of the National Cancer Institute, 2004
- Induction of Grp78/BiP by Translational BlockPublished by Elsevier BV ,2003
- Endoplasmic Reticulum Chaperone Protein GRP78 Protects Cells from Apoptosis Induced by Topoisomerase InhibitorsPublished by Elsevier BV ,2003
- All Roads Lead to ATF4Developmental Cell, 2003
- The multistep nature of cancerTrends in Genetics, 1993